PATL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.451800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.744400E-01
Normal-vs-Stage2
8.172800E-01
Normal-vs-Stage3
2.627200E-01
Normal-vs-Stage4
5.122800E-01
Stage1-vs-Stage2
3.705000E-01
Stage1-vs-Stage3
4.267800E-01
Stage1-vs-Stage4
2.755400E-01
Stage2-vs-Stage3
9.841900E-02
Stage2-vs-Stage4
4.772400E-01
Stage3-vs-Stage4
1.429380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.724000E-01
Normal-vs-AfricanAmerican
9.239600E-01
Normal-vs-Asian
8.775600E-01
Caucasian-vs-AfricanAmerican
8.557400E-01
Caucasian-vs-Asian
7.534200E-01
AfricanAmerican-vs-Asian
7.690000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.333200E-01
Normal-vs-Female
9.685200E-01
Male-vs-Female
8.460600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.042600E-01
Normal-vs-Age(41-60Yrs)
6.272800E-01
Normal-vs-Age(61-80Yrs)
9.280800E-01
Normal-vs-Age(81-100Yrs)
9.227200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.143040E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.349800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.193400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.107900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.821000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.764200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.667800E-01
Normal-vs-Daily Drinker
9.148200E-01
Normal-vs-Weekly Drinker
9.161800E-01
Normal-vs-Occasional Drinker
7.455200E-01
Normal-vs-Social Drinker
7.719000E-01
Non Drinker-vs-Daily Drinker
9.274600E-01
Non Drinker-vs-Weekly Drinker
6.153800E-01
Non Drinker-vs-Occasional Drinker
3.451600E-01
Non Drinker-vs-Social Drinker
4.063200E-01
Daily Drinker-vs-Weekly Drinker
7.117000E-01
Daily Drinker-vs-Occasional Drinker
4.544600E-01
Daily Drinker-vs-Social Drinker
5.138000E-01
Weekly Drinker-vs-Occasional Drinker
7.624800E-01
Weekly Drinker-vs-Social Drinker
8.105400E-01
Occasional Drinker-vs-Social Drinker
9.556000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.944200E-01
Normal-vs-Grade 2
4.306100E-02
Normal-vs-Grade 3
2.491800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.17880000000071E-05
Grade 1-vs-Grade 3
1.82377999999872E-05
Grade 1-vs-Grade 4
3.944200E-01
Grade 2-vs-Grade 3
3.074200E-01
Grade 2-vs-Grade 4
4.306100E-02
Grade 3-vs-Grade 4
2.491800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.162000E-01
Normal-vs-NonDiabetic
9.703600E-01
Diabetic-vs-NonDiabetic
6.342000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.418800E-01
Normal-vs-NoPancreatitis
9.489000E-01
Pancreatitis-vs-NoPancreatitis
1.398360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.159600E-01
Normal-vs-N1
8.478200E-01
N0-vs-N1
3.036200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.827600E-01
Normal-vs-TP53-NonMutant
7.380400E-01
TP53-Mutant-vs-TP53-NonMutant
1.66901999999469E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
